Saltar al contenido

Patents

  • EP22382009. Mayán MD, Rodríguez-Candela M, Acea Nebril B, Santiago Freijane P. Method for the treatment of BRCA1/2 mutated cancer. 11/01/2022. Fundación Profesor Novoa Santos. Requested.
  • PCT/EP2021/077487. Mayán MD, Varela-Vázqued A, Guitián-Caamaño A, Paula Carpintero-Fernández P, Varela-Eirín M, Fonseca E, Quindos M, Calleja Chucla T. Connexin 43 for use in the treatment of a cancer type characterized by the activation of a mitogen activated protein kinase. 06/10/2021. Fundación Profesor Novoa Santos. Patent application approved.
  • EP21382657. Mayán MD, Carpintero-Fernández P, García-Yuste A, Acea Nebril B, Fonseca E. Connexin43 for use in the treatment of retinoblastoma protein positive tumours. 20/07/2021. Fundación Profesor Novoa Santos. Requested.
  • PCT/ES2020/070269. Mayán MD, Acea Nebril B, Varela-Eirín M, Rodríguez-Candela Mateos M, Díaz-Carballa C, Fonseca E, Barrio LC, Escudero A. Composition for the treatment of negative side effects of chemotherapy and/or radiotherapy. 27/04/2021. Fundación Profesor Novoa Santos. Patent Licensed to Alodia Farmacéutica.
  • PCT/EP2020/071242. Mayán MD, Varela-Eirín M, Castro-Iglesias A, Vázquez-Sentis E, Mascarenas JL, Learte-Aymamí S, Caeiro JR, Pazos E. Peptides for use as senotherapeutic agents. 06/04/2021. Fundación Profesor Novoa Santos. Patent application approved.
  • PCT/US2014/045229. Mayán MD, Blanco FJ, Carpintero-Fernández P; Goldberg GS. Compositions and methods to treat inflammatory joint diseases United States of America. 02/07/2014. Patent application aproved.
  • P200201570. Camiña Darriba MF, Mayán Santos M, Villamarín Rodríguez-Segade S. Method for identification of the allelos M, S and Z of alpha-1-antitrypsin using restriction enzymes. 16/09/2005. Universidad de Santiago de Compostela.